↓ Skip to main content

Beta‐blockers for hypertension

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
29 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Beta‐blockers for hypertension
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd002003.pub4
Pubmed ID
Authors

Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH, Wiysonge, Charles Shey, Bradley, Hazel A, Volmink, Jimmy, Mayosi, Bongani M, Mbewu, Anthony, Opie, Lionel H

Abstract

This review is an update of the Cochrane Review published in 2007, which assessed the role of beta-blockade as first-line therapy for hypertension.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 2 7%
Researcher 2 7%
Student > Master 2 7%
Student > Postgraduate 1 3%
Student > Bachelor 1 3%
Other 3 10%
Unknown 18 62%
Readers by discipline Count As %
Medicine and Dentistry 8 28%
Unspecified 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Unknown 18 62%

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 October 2016.
All research outputs
#705,374
of 12,923,198 outputs
Outputs from Cochrane database of systematic reviews
#2,345
of 10,415 outputs
Outputs of similar age
#12,937
of 250,803 outputs
Outputs of similar age from Cochrane database of systematic reviews
#133
of 514 outputs
Altmetric has tracked 12,923,198 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,415 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.3. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,803 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 514 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.